Corbus Pharmaceuticals Inc. (CRBP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Corbus Pharmaceuticals I...

    NASDAQ: CRBP · Real-Time Price · USD
    14.83
    1.82 (13.99%)
    At close: Oct 03, 2025, 3:59 PM
    14.98
    1.01%
    After-hours: Oct 03, 2025, 07:48 PM EDT

    Corbus Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.2 -0.59 -0.25 -1.66
    PEG Ratio
    		 0.05 -0.37 0.03 0.02
    PS Ratio
    		 n/a n/a n/a 85.93
    PB Ratio
    		 0.90 -3.79 0.42 1.10
    P/FCF Ratio
    		 -3.08 -0.72 -0.37 -1.57
    P/OCF Ratio
    		 -3.08 -0.72 -0.37 -1.57
    OCF/S Ratio
    		 n/a n/a n/a -54.65
    Debt / Equity Ratio
    		 0.02 -3.02 0.76 0.38
    Quick Ratio
    		 12.94 0.74 4.76 5.89
    Current Ratio
    		 12.94 0.74 4.76 5.89
    Asset Turnover
    		 n/a n/a n/a 0.01
    Interest Coverage
    		 -26.03 -15.42 -16.34 -30.59
    Return on Equity
    		 -0.28 6.46 -1.69 -0.66
    Return on Assets
    		 -0.26 -1.58 -0.84 -0.42
    Return on Invested Capital
    		 -0.33 -3.21 -0.6 -0.58
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a -0.86
    Net Profit Margin
    		 n/a n/a n/a -51.66
    Pretax Profit Margin
    		 n/a n/a n/a -51.76
    Operating Profit Margin
    		 n/a n/a n/a -63.5
    FCF Margin
    		 n/a n/a n/a -54.71
    EBITDA Margin
    		 n/a n/a n/a -62.35

    Add to Watchlist